Fabienne Mackay
Direktor/Vorstandsmitglied bei Ena Respiratory Pty Ltd.
Ursprung des Netzwerks ersten Grades von Fabienne Mackay
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Ena Respiratory Pty Ltd.
Ena Respiratory Pty Ltd. BiotechnologyHealth Technology Ena Respiratory Pty Ltd. operates as a biotechnology company. It develops novel, synthetic innate immunomodulators for the prevention of respiratory viral and bacterial infections. The company is headquartered in Melbourne, Australia.
5
| Holding Company | Biotechnology | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Fabienne Mackay
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Otifex Therapeutics Pty Ltd.
Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia. | Medical Specialties | Director/Board Member Director/Board Member | |
Monash University
Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Undergraduate Degree Doctorate Degree | |
Uniseed Management Pty Ltd.
Uniseed Management Pty Ltd. Investment ManagersFinance Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia. | Investment Managers | Investment Committee Member | |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Great Ormond Street Hospital Children's Charity
Great Ormond Street Hospital Children's Charity Investment Trusts/Mutual FundsMiscellaneous Great Ormond Street Hospital Children's Charity is a non-profit organization which engages in fundraising and charitable activities to help children's who have medical needs. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
University of Strasbourg | College/University | Doctorate Degree | |
Sangamo Therapeutics UK Ltd.
Sangamo Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics UK Ltd. researches and develops transcription factors in the regulation of genes. The company was founded on April 21, 1999 and is headquartered in Cheltenham, the United Kingdom. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
BACE Therapeutics Pty Ltd. | Director/Board Member | ||
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
DMTC Ltd. | Corporate Officer/Principal | ||
Adned Pty Ltd. | Chief Executive Officer | ||
d3 Medicine LLC
d3 Medicine LLC Pharmaceuticals: MajorHealth Technology d3 Medicine LLC develops drugs and medicines. It is strategic advisory company focused on developing medicines for use in indications including infectious diseases, oncology, and inflammation. The company was founded by Craig Rayner in 2012 and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Chairman | |
Gene Shears Pty Ltd. | Chief Executive Officer | ||
GBS Venture Partners Pty Ltd.
GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Investment Managers | Corporate Officer/Principal | |
Johnson & Johnson Research Pty Ltd. | Corporate Officer/Principal | ||
PRO MEDICUS LIMITED | Services to the Health Industry | Director/Board Member | |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cortical Pty Ltd.
Cortical Pty Ltd. BiotechnologyHealth Technology Cortical Pty Ltd. discovers and develops medical drugs for the treatment of inflammatory and proliferative diseases. The company was founded in 2003 by Eric F. Morand and Magdy N. Iskander and is headquartered in Clayton, Australia. | Biotechnology | Director/Board Member | |
Exonate Ltd.
Exonate Ltd. Medical/Nursing ServicesHealth Services Exonate engages in the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. It develops SPHINXes, a pipeline of novel small molecule inhibitors. The company was founded by David Owen Bates, Lucy Donaldson, Steeven J. harper and Catherine Beech in 2013 and is headquartered in Nottingham, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Nexgen Plants Pty Ltd.
Nexgen Plants Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Nexgen Plants Pty Ltd. develops anti-viral technology solutions that enables virus resistant plant varieties to be developed for major food, fibre, energy and ornamental crops. The company was founded in 2013 and is headquartered in St. Lucia, Australia. | Miscellaneous Commercial Services | Director/Board Member | |
OccuRx Pty Ltd
OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Biotechnology | Director/Board Member | |
Fibrotech Therapeutics Pty Ltd.
Fibrotech Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Fibrotech Therapeutics Pty Ltd develops novel drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as kidney disease, chronic heart failure, pulmonary fibrosis, and arthritis. The company was founded by Richard Ernest Gilbert, Darren James Kelly, Spencer J Williams, Steven C Zammit, David Stapleton, Henry Krum and Yuan Zhang in 2006 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member | |
Hatchtech Pty Ltd.
Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member | |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree | |
Solvanix Pty Ltd.
Solvanix Pty Ltd. BiotechnologyHealth Technology Solvanix Pty Ltd. develops novel therapy for improving stability and reducing the aggregation of fully human antibodies. The company was founded by Daniel Christ in 2014 and is headquartered in Darlinghurst, Australia. | Biotechnology | Director/Board Member |
Statistik
International
Australien | 22 |
Vereinigtes Königreich | 5 |
Vereinigte Staaten | 4 |
Frankreich | 2 |
Sektoral
Health Technology | 13 |
Commercial Services | 5 |
Consumer Services | 4 |
Finance | 3 |
Health Services | 3 |
Operativ
Director/Board Member | 20 |
Corporate Officer/Principal | 8 |
Doctorate Degree | 3 |
Chief Executive Officer | 3 |
Undergraduate Degree | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
John Kurek | 13 |
Leigh Farrell | 13 |
Christophe Demaison | 7 |
Chris Smith | 2 |
Francesca Mercuri | 1 |
- Börse
- Insiders
- Fabienne Mackay
- Unternehmensverbindungen